Biological warfare and bioterrorism

Nicholas Beeching; David A.B. Dance; Alastair R.O. Miller; Robert C. Spencer

doi:10.1136/bmj.324.7333.336

Biological warfare and bioterrorism

Nicholas Beeching, David A.B. Dance, Alastair R.O. Miller, Robert C. Spencer

Clinical Sciences and International Public Health

Research output: Contribution to journal › Review article › peer-review

74 Citations (Scopus)

Abstract

Since the terrorist attack on the United States in September 2001 attention has been focused on the threat of biological warfare. The disruptive effects of deliberate release of anthrax in civilian settings have been well documented, and several other pathogens could also be used as biological weapons. We have described the key features of such pathogens, how they might be used in biological warfare, and the clinical syndromes they cause. We also discuss the medical and logistic response to their possible use.

Original language	English
Pages (from-to)	336-339
Number of pages	4
Journal	BMJ
Volume	324
Issue number	7333
DOIs	https://doi.org/10.1136/bmj.324.7333.336
Publication status	Published - 9 Feb 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmj.324.7333.336

Cite this

@article{2bc9e0d7e13b4b1484e2e2c8fee2b49c,

title = "Biological warfare and bioterrorism",

abstract = "Since the terrorist attack on the United States in September 2001 attention has been focused on the threat of biological warfare. The disruptive effects of deliberate release of anthrax in civilian settings have been well documented, and several other pathogens could also be used as biological weapons. We have described the key features of such pathogens, how they might be used in biological warfare, and the clinical syndromes they cause. We also discuss the medical and logistic response to their possible use.",

author = "Nicholas Beeching and Dance, \{David A.B.\} and Miller, \{Alastair R.O.\} and Spencer, \{Robert C.\}",

year = "2002",

month = feb,

day = "9",

doi = "10.1136/bmj.324.7333.336",

language = "English",

volume = "324",

pages = "336--339",

journal = "BMJ",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7333",

}

TY - JOUR

T1 - Biological warfare and bioterrorism

AU - Beeching, Nicholas

AU - Dance, David A.B.

AU - Miller, Alastair R.O.

AU - Spencer, Robert C.

PY - 2002/2/9

Y1 - 2002/2/9

N2 - Since the terrorist attack on the United States in September 2001 attention has been focused on the threat of biological warfare. The disruptive effects of deliberate release of anthrax in civilian settings have been well documented, and several other pathogens could also be used as biological weapons. We have described the key features of such pathogens, how they might be used in biological warfare, and the clinical syndromes they cause. We also discuss the medical and logistic response to their possible use.

AB - Since the terrorist attack on the United States in September 2001 attention has been focused on the threat of biological warfare. The disruptive effects of deliberate release of anthrax in civilian settings have been well documented, and several other pathogens could also be used as biological weapons. We have described the key features of such pathogens, how they might be used in biological warfare, and the clinical syndromes they cause. We also discuss the medical and logistic response to their possible use.

U2 - 10.1136/bmj.324.7333.336

DO - 10.1136/bmj.324.7333.336

M3 - Review article

SN - 0959-8146

VL - 324

SP - 336

EP - 339

JO - BMJ

JF - BMJ

IS - 7333

ER -

Biological warfare and bioterrorism

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this